Home / Resource Library / Data From the CAPTIVATE Study’s uMRD Cohort Suggest Role for Fixed-Duration Therapy in CLL/SLL

Data From the CAPTIVATE Study’s uMRD Cohort Suggest Role for Fixed-Duration Therapy in CLL/SLL

ASH 2020: Interview with John N. Allan, MD who discusses a study investigating fixed duration treatment for first line chronic lymphocytic leukemia.